Issue 7, 2019

Anti-biofilm activity of quinazoline derivatives against Mycobacterium smegmatis

Abstract

Bacteria employ a number of mechanisms to resist the effects of antibiotics, including the formation of biofilms. We explored the anti-biofilm capabilities of a library of compounds based upon a 2-aminoquinazoline (2-AQ) scaffold against Mycobacterium smegmatis. This study resulted in the identification of 2-AQ derivatives with biofilm inhibition activity against M. smegmatis.

Graphical abstract: Anti-biofilm activity of quinazoline derivatives against Mycobacterium smegmatis

Supplementary files

Article information

Article type
Research Article
Submitted
12 Mar 2019
Accepted
18 May 2019
First published
23 May 2019

Med. Chem. Commun., 2019,10, 1177-1179

Anti-biofilm activity of quinazoline derivatives against Mycobacterium smegmatis

K. E. Cox and C. Melander, Med. Chem. Commun., 2019, 10, 1177 DOI: 10.1039/C9MD00156E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements